Sponsors

Specific ELISA for varicella immune status

Binding Site’s new VaccZyme VZV glycoprotein IgG low-level enzyme-linked immunosorbent assay (ELISA) is a sensitive and specific quantitative assay for use in the accurate determination of immune status to varicella zoster virus (VZV), an important test for immunocompromised patients and pregnant women.

The kit has a high sensitivity measuring range of 10–810 miu/mL, which is ideal for the accurate measurement of post-vaccination antibody levels. High assay specificity is achieved using purified viral glycoprotein as the capture antigen, in common with the ‘gold standard’ FAMA reference method, rather than the viral cell lysate used in many alternative assays. In addition, the VaccZyme VZV glycoprotein ELISA is easily automated.
www.bindingsite.co.uk

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025